Bill

Bill > HR3082


US HR3082

US HR3082
Evidence-Based Drug Policy Act of 2025


summary

Introduced
04/29/2025
In Committee
04/29/2025
Crossed Over
Passed
Dead

Introduced Session

119th Congress

Bill Summary

A BILL To repeal section 704(b)(12) of the Office of National Drug Control Policy Reauthorization Act of 1998, and for other purposes.

AI Summary

This bill, titled the "Evidence-Based Drug Policy Act of 2025", aims to repeal section 704(b)(12) of the Office of National Drug Control Policy Reauthorization Act of 1998. By removing this specific section from the existing law, the bill effectively eliminates a particular provision related to the Office of National Drug Control Policy (ONDCP). While the specific details of the repealed section are not provided in the text, the bill suggests a potential update or modification to existing drug policy regulations. The proposed change appears to be part of an effort to refine or streamline drug control policy, though without additional context, the precise implications of this repeal cannot be fully determined from the bill text alone.

Committee Categories

Government Affairs

Sponsors (2)

Last Action

Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (on 04/29/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...